Anguidine | 2270-40-8

• 物质功能分类: 分析化学 - 标准品 - 食品和化妆品标准品
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: Anguidine
• 英文别名: (11-acetyloxy-10-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl)methyl acetate
• CAS: 2270-40-8
• 化学式: C₁₉H₂₆O₇
• 分子量: 366.4
• InChiKey: AUGQEEXBDZWUJY-UHFFFAOYSA-N

物化性质

• 熔点：
  162-164℃
• 沸点：
  407.62°C (rough estimate)
• 密度：
  1.1821 (rough estimate)
• 闪点：
  2 °C
• 溶解度：
  DMF：30mg/mL； DMF:PBS (pH 7.2) (1:4)：0.2 mg/mL； DMSO：30mg/mL；乙醇：20mg/mL
• 物理描述：
  Solid
• 颜色/状态：
  Solid
• 蒸汽压力：
  3.8X10-9 mm Hg at 25 °C (est)
• 稳定性/保质期：

  These toxins are heat and uv light stable... and capable of long-term storage... . /Trichothecenes/

• 旋光度：
  Specific optical rotation = -27 deg at 20 °C/D
• 分解：
  Hazardous decomposition products formed under fire conditions. - Carbon oxides
• 保留指数：
  2426

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  26
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.79
• 拓扑面积：
  94.6
• 氢给体数：
  1
• 氢受体数：
  7

ADMET

代谢

Trichothecenes是一组主要由Fusarium属真菌产生的霉菌毒素。消费者特别关注来自食用动物的食物安全和T-2毒素、脱氧雪腐镰刀菌烯醇（DON）、雪腐镰刀菌烯醇（NIV）、镰刀菌烯-X（FX）、二乙酰氧基香豆素（DAS）、3-乙酰脱氧雪腐镰刀菌烯醇（3-aDON）和15-乙酰脱氧雪腐镰刀菌烯醇（15-aDON）及其代谢物在啮齿类动物、猪、反刍动物、家禽和人体内的代谢情况。这些霉菌毒素的代谢途径非常不同。T-2毒素在动物体内的主要代谢途径是水解、羟基化、脱环氧化和结合。转化为HT-2毒素后，它在C-3'位置进一步羟基化，生成3'-羟基-HT-2毒素，这被认为是一种活化途径，而T-2毒素转化为T-2四醇是一种动物体内的失活途径。T-2毒素在动物体内的典型代谢物是HT-2毒素、T-2三醇、T-2四醇、新鞘氨醇（NEO）、3'-羟基-HT-2和3'-羟基-T-2，而在人体内HT-2毒素是主要代谢物。脱环氧化是动物体内解毒的重要途径。脱环氧产物DOM-1和脱环氧-NIV分别是大多数动物体内DON和NIV的主要代谢物。然而，这两种代谢物在人体内并未发现。乙酰衍生物3-aDON、15-aDON和FX可以迅速发生脱乙酰作用。DAS在动物体内代谢为15-单乙酰氧基香豆素（15-MAS）通过C-4脱乙酰化，然后转化为香豆三醇（SCP）通过C-15脱乙酰化。最后，环氧基团丢失，生成脱环氧-SCP。脱环氧-15-MAS也是DAS的主要代谢物。15-MAS是人类皮肤中的主要代谢物。对Trichothecenes代谢的综述将有助于人们深入了解这些毒素在动物和人体内的未来命运，并为食品安全的风险评估提供基本信息。

Trichothecenes are a group of mycotoxins mainly produced by the fungi of Fusarium genus. Consumers are particularly concerned over the toxicity and food safety of trichothecenes and their metabolites from food-producing animals. The metabolism of T-2 toxin, deoxynivalenol (DON), nivalenol (NIV), fusarenon-X (FX), diacetoxyscirpenol (DAS), 3-acetyldeoxy-nivalenol (3-aDON), and 15-acetyldeoxynivalenol (15-aDON) in rodents, swine, ruminants, poultry, and humans are reviewed in this article. Metabolic pathways of these mycotoxins are very different. The major metabolic pathways of T-2 toxin in animals are hydrolysis, hydroxylation, de-epoxidation, and conjugation. After being transformed to HT-2 toxin, it undergoes further hydroxylation at C-3' to yield 3'-hydroxy-HT-2 toxin, which is considered as an activation pathway, whereas transformation from T-2 to T-2 tetraol is an inactivation pathway in animals. The typical metabolites of T-2 toxin in animals are HT-2 toxin, T-2 triol, T-2 tetraol, neosolaniol (NEO), 3'-hydroxy-HT-2, and 3'-hydroxy-T-2, whereas HT-2 toxin is the main metabolite in humans. De-epoxidation is an important pathway for detoxification in animals. De-epoxy products, DOM-1, and de-epoxy-NIV are the main metabolites of DON and NIV in most animals, respectively. However, the two metabolites are not found in humans. Deacetyl can occur rapidly on the acetyl derivatives, 3-aDON, 15-aDON, and FX. DAS is metabolized in animals to 15-monoacetoxyscirpenol (15-MAS) via C-4 deacetylation and then transformed to scirpentriol (SCP) via C-15 deacetylation. Finally, the epoxy is lost, yielding de-epoxy-SCP. De-epoxy-15-MAS is also the main metabolite of DAS. 15-MAS is the main metabolite in human skin. The review on the metabolism of trichothecenes will help one to well understand the fate of these toxins' future in animals and humans, as well as provide basic information for the risk assessment of them for food safety.

来源:Hazardous Substances Data Bank (HSDB)

代谢

三环烯类化合物，如T-2毒素、二乙酰氧基雪腐烯醇和脱氧雪腐镰刀菌烯醇，在饲料中存在，它们主要通过两相代谢途径进行代谢。在第一阶段进行氧化和水解，而第二阶段则将转化产物与葡萄糖醛酸结合；此外，环氧环会被肠道微生物群裂解。T-2毒素的代谢物包括HT-2毒素、3'-羟基-T-2毒素、3'-羟基-HT-2毒素、新雪腐醇、4-去乙酰新雪腐醇、T-2三醇、T-2四醇和去环氧T-2四醇。二乙酰氧基雪腐烯醇转化为15-单乙酰氧基雪腐烯醇、雪腐三醇、去环氧15-单乙酰氧基雪腐烯醇和去环氧雪腐三醇。脱氧雪腐镰刀菌烯醇没有广泛的代谢；仅假定产生脱氧雪腐镰刀菌烯醇葡萄糖苷酸和去环氧脱氧雪腐镰刀菌烯醇。由于三环烯类化合物迅速代谢，通过分析猪源样本诊断中毒几乎是不可能的；同样地，三环烯代谢物在食用组织中富集的可能性被认为是低的。

Trichothecenes like T-2 toxin, diacetoxyscirpenol, and deoxynivalenol, which occur in feed, are metabolized preponderant in a biphasic way. Oxidation and hydrolysis are carried out in phase 1, while the transformation products are conjugated with glucuronic acid in phase 2; in addition, the epoxide ring is cleaved by the gut microflora. Metabolites of T-2 toxin are HT-2 toxin, 3'-hydroxy-T-2 toxin, 3'-hydroxy-HT-2 toxin, neosolaniol, 4-deacetylneosolaniol, T-2 triol, T-2 tetraol, and de-epoxide T-2 tetraol. Diacetoxyscirpenol is transformed to 15-monoacetoxyscirpenol, scirpenetriol, de-epoxide 15-moneacetoxyscirpenol, and de-epoxide scirpenetriol. Deoxynivalenol undergoes no extensive metabolism; only the production of deoxynivalenol glucuronide and de-epoxide deoxynivalenol is assumed. As trichothecenes are rapid metabolized, the diagnosis of an intoxication by the analysis of samples of pig origin should be hardly possible; for the same reason, the possibility of an enrichment of trichothecene metabolites in edible tissues is graded as low.

来源:Hazardous Substances Data Bank (HSDB)

代谢

曲霉菌素是亲脂性的，因此可以通过皮肤、肠道和肺粘膜轻易吸收。它们主要通过肝脏中的细胞色素P-450和曲霉菌素特异性羧酸酯酶活性进行代谢，尽管其他组织，如肾脏、脾脏和肠道也表现出一些代谢活性。曲霉菌素通过水解、羟基化、脱环氧化和葡萄糖苷酸化等反应代谢转化为毒性较低的代谢物。代谢物通过尿液和粪便排出。

Trichothecenes are lipophilic and thus easily absorbed through the skin, gut, and pulmonary mucosa. They are metabolized mainly by cytochrome P-450 and trichothecene-specific carboxylesterase activity in the liver, although other tissues such as the kidney, spleen, and intestine also show some metabolic activity. Trichothecenes are metabolically transformed to less toxic metabolites by such reactions as hydrolysis, hydroxylation, de-epoxidation, and glucuronidation. Metabolites are excreted in the urine and feces. (L1910, L1949)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 毒性总结

与许多其他真菌毒素不同，三环烯类不需要代谢激活就能发挥其生物活性，而是直接与细胞组分反应。三环烯类对大多数真核细胞具有细胞毒性，这是由于它们具有强大的抑制蛋白质合成能力。它们通过自由穿过质膜并特异性地与核糖体高亲和力结合来实现这一点。具体来说，它们干扰位于大28S核糖核酸3'端的多肽转移酶的活性位点，并抑制蛋白质合成的起始、延伸或终止步骤，以及导致多核糖体解聚。蛋白质合成是所有组织的必要功能，但在积极和快速生长和分裂的细胞组织中，对毒素非常敏感。此外，与核糖体的结合被认为会激活与免疫反应和凋亡相关的下游信号事件中的蛋白质，例如有丝分裂原活化蛋白激酶。这被称为核糖毒性应激反应。三环烯类还可能诱导一些膜结构的变化，导致脂质过氧化增加和线粒体中电子传递活性的抑制。它们还可以通过产生活性氧种进一步诱导凋亡。三环烯类的进一步次要效果包括抑制RNA和DNA合成，以及抑制有丝分裂。(L1948, L1949, A2962, A2963, A2964, A2980)

Unlike many other mycotoxins, trichothecenes do not require metabolic activation to exert their biological activity, instead directly reacting with cellular components. Trichothecenes are cytotoxic to most eukaryotic cells due to their powerful ability to inhibit protein synthesis. They do this by freely moving across the plasma membrane and binding specifically to ribosomes with high-affinity. Specifically, they interfere with the active site of peptidyl transferase at the 3'-end of large 28S ribosomal RNA and inhibit the initiation, elongation or termination step of protein synthesis, as well as cause polyribosomal disaggregation. Protein synthesis is an essential function in all tissues, but tissues where cells are actively and rapidly growing and dividing are very susceptible to the toxins. Additionally, binding to ribosomes is thought to activate proteins in downstream signalling events related to immune response and apoptosis, such as mitogen-activated protein kinases. This is known as ribotoxic stress response. Trichothecenes may also induce some alterations in membrane structure, leading to increased lipid peroxidation and inhibition of electron transport activity in the mitochondria. They can further induce apoptosis through generation of reactive oxygen species. Further secondary effects of trichothecenes include inhibition of RNA and DNA synthesis, and also inhibition of mitosis. (L1948, L1949, A2962, A2963, A2964, A2980)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 致癌物分类

对人类无致癌性（未列入国际癌症研究机构IARC清单）。

No indication of carcinogenicity to humans (not listed by IARC).

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 健康影响

Trichothecenes是一种多器官有毒物质，包括厌食和体重下降、生长迟缓、神经系统疾病、心血管改变、免疫抑制、血液凝固失调、皮肤毒性、生殖能力下降、骨髓损伤以及食源性的白细胞减少症。

Trichothecenes have multiorgan effects including anoerxia and weight loss, growth retardation, nervous disorders, cardiovascular alterations, immunodepression, hemostatic derangements, skin toxicity, decreased reproductive capacity, bone marrow damage, and alimentary toxic aleukia. (L1948, L1949, A2964)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 暴露途径

口服、皮肤、吸入和parenteral（被污染的药物）。

Oral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 症状

接触皮肤或口服摄入后，三环唑霉毒素会导致皮肤或肠粘膜迅速出现刺激反应，包括皮肤刺激、灼热和瘙痒、皮疹或水泡，以及出血。眼睛接触可能导致流泪、眼睛疼痛、结膜炎、眼部烧灼感和长达1周的视力模糊。症状还包括恶心、呕吐、疲劳、呼吸困难以及导致低血压和休克的急性血管效应。

After direct dermal application or oral ingestion, the trichothecene mycotoxins can cause rapid irritation to the skin or intestinal mucosa, including skin irritation, burning and itching, rash or blisters, and bleeding. Eye contact can cause tearing, eye pain, conjunctivitis, burning sensations about the eyes, and blurred vision for up to 1 week. Symptoms also include nausea, vomiting, fatigue, dyspnea, and acute vascular effects leading to hypotension and shock. (L1948, L1949)

来源:Toxin and Toxin Target Database (T3DB)

吸收、分配和排泄

在大鼠和小鼠局部应用单一剂量的/(3)H-diacetoxyscirpenol/([(3)H]DAS)后的90分钟内，大鼠吸收并保留了更多的[(3)H]DAS，并且通过尿液和粪便排出的放射性活性比小鼠少。治疗后24小时内，大鼠吸收、排出并保留的[(3)H]DAS大约是小鼠的两倍（p < 0.05或< 0.005）。治疗7天后，大鼠吸收的[(3)H]DAS量比小鼠多出四倍以上（13.1% 对 57.5%；p < 0.005）。然而，小鼠组织保留的放射性活性的比例（4.1%）高于大鼠（1.0%；p < 0.05）。大鼠的总放射性标记排出量大约是小鼠的六倍（56% 对 9%；p < 0.005）。大鼠尿液中排出的比例与粪便中的比例大约是2比1（37% 对 18%），而小鼠大约是3.5比1（7% 对 2%）。当数据以组织中的吸收剂量百分比或每克组织的特定放射性活性（dpm）表示时，大鼠和小鼠的[(3)H]DAS组织分布的时间过程存在显著差异。这些结果表明，局部应用的[(3)H]DAS在大鼠和小鼠中的吸收、排出和组织分布模式不同。

During the 90-min period after topical application of a single dose of /(3)H-diacetoxyscirpenol/ ([(3)H]DAS), the rat absorbed and retained more [(3)H]DAS and excreted less radioactivity through urine and feces than the mouse. By 24 hr after treatment, the rat had absorbed, excreted, and retained about twice as much [(3)H]DAS as had the mouse (p < 0.05 or < 0.005). At 7 days posttreatment, the rat had absorbed more than four times the amount of [(3)H]DAS than had the mouse (13.1 vs 57.5%; p < 0.005). However, tissues of the mouse retained a higher proportion of administered radioactivity (4.1%) than those of the rat (1.0%; p < 0.05). Total excretion of radiolabel by the rat was approximately sixfold higher than that of the mouse (56 vs 9%; p < 0.005). The ratio of excretion in urine to that in feces in the rat was about 2 to 1 (37 vs 18%) and in the mouse was about 3.5 to 1 (7 vs 2%). Significant differences in the time course of tissue distribution of [(3)H]DAS in the rat and mouse were found when data were expressed as the percentage of absorbed dose present in tissues or as specific radioactivity (dpm) per gram tissue. These results demonstrated a different pattern of absorption, excretion, and tissue distribution of topically administered [(3)H]DAS in rats and mice.

来源:Hazardous Substances Data Bank (HSDB)

安全信息

• 危险等级：
  6.1(a)
• 危险品标志：
  Xn,T+,F,T
• 安全说明：
  S16,S36/37,S45,S53
• 危险类别码：
  R20/21/22,R36/38,R36,R26/27/28,R11
• WGK Germany：
  3
• 海关编码：
  29329990
• 危险品运输编号：
  UN 3462 6.1/PG 2
• RTECS号：
  YD0112000
• 包装等级：
  II
• 危险类别：
  6.1(a)

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : Diacetoxyscirpenol solution
Index-No. : 608-001-00-3
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 2270-40-8
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Flammable liquids (Category 2), H225
Acute toxicity, Oral (Category 4), H302
Acute toxicity, Inhalation (Category 4), H332
Acute toxicity, Dermal (Category 4), H312
Eye irritation (Category 2), H319
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
F Highly flammable R11
Xn Harmful R20/21/22
Xi Irritant R36
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Danger
Hazard statement(s)
H225 Highly flammable liquid and vapour.
H302 Harmful if swallowed.
H312 Harmful in contact with skin.
H319 Causes serious eye irritation.
H332 Harmful if inhaled.
Precautionary statement(s)
P210 Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P280 Wear protective gloves/ protective clothing.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s) F Highly flammable
Xn Harmful
R-phrase(s)
R11 Highly flammable.
R20/21/22 Harmful by inhalation, in contact with skin and if swallowed.
R36 Irritating to eyes.
S-phrase(s)
S16 Keep away from sources of ignition - No smoking.
S36/37 Wear suitable protective clothing and gloves.
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Mixtures
Chemical characterization : Natural product
Synonyms : 12,13-Epoxytrichothec-9-ene-3,4,15-triol-4,15-diacetatesolution
Anguidinsolution
4β,15-Diacetoxy-3α-hydroxy-12,13 epoxy-trichothec-9-enesolution
DAS
Formula : C19H26O7 C19H26O7
Molecular Weight : 366,41 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
Acetonitrile
CAS-No. 75-05-8 Flam. Liq. 2; Acute Tox. 4; Eye <= 100 %
EC-No. 200-835-2 Irrit. 2; H225, H302 + H312 +
Index-No. 608-001-00-3 H332, H319
Registration number 01-2119471307-38-XXXX
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
Acetonitrile
CAS-No. 75-05-8 F, Xn, R11 - R20/21/22 - R36 <= 100 %
EC-No. 200-835-2
Index-No. 608-001-00-3
Registration number 01-2119471307-38-XXXX
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with
water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
Use water spray to cool unopened containers.

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure adequate ventilation.
Remove all sources of ignition. Evacuate personnel to safe areas. Beware of vapours accumulating to
form explosive concentrations. Vapours can accumulate in low areas.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Contain spillage, and then collect with an electrically protected vacuum cleaner or by wet-brushing and
place in container for disposal according to local regulations (see section 13).
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Keep away from sources of ignition - No smoking.Take measures to prevent the build up of electrostatic
charge.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Recommended storage temperature: -20 °C
Handle and store under inert gas.
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Tightly fitting safety goggles. Faceshield (8-inch minimum). Use equipment for eye protection
tested and approved under appropriate government standards such as NIOSH (US) or EN
166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Full contact
Material: Fluorinated rubber
Minimum layer thickness: 0,7 mm
Break through time: 480 min
Material tested:Vitoject® (KCL 890 / Z677698, Size M)
Splash contact
Material: butyl-rubber
Minimum layer thickness: 0,3 mm
Break through time: 480 min
Material tested:Butoject® (KCL 897 / Z677647, Size M)
data source: KCL GmbH, D-36124 Eichenzell, phone [phone], test method: EN374
If used in solution, or mixed with other substances, and under conditions which differ from EN 374,
contact the supplier of the CE approved gloves. This recommendation is advisory only and must
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of
anticipated use by our customers. It should not be construed as offering an approval for any
specific use scenario.
Body Protection
Complete suit protecting against chemicals, Flame retardant antistatic protective clothing, The type
of protective equipment must be selected according to the concentration and amount of the
dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: liquid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: -45 °C
point
f) Initial boiling point and 81 - 82 °C at 1.013 hPa
boiling range
g) Flash point 2 °C
h) Evapouration rate 5,79
i) Flammability (solid, gas) no data available
j) Upper/lower Upper explosion limit: 16 %(V)
flammability or Lower explosion limit: 4,4 %(V)
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density 0,782 g/cm3
n) Water solubility no data available
o) Partition coefficient: n- log Pow: -0,34
octanol/water
p) Auto-ignition 274 °C
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
Heat, flames and sparks. Extremes of temperature and direct sunlight.
Incompatible materials
Bases, Oxidizing agents, Alkali metals, Reducing agents, acids
Hazardous decomposition products
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
Treat as cyanide poisoning., Always have on hand a cyanide first-aid kit, together with proper instructions.,
The onset of symptoms is generally delayed pending conversion to cyanide., Headache, Dizziness, Rash,
Cyanosis, excitement, depression, Drowsiness

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Burn in a chemical incinerator equipped with an afterburner and scrubber but exert extra care in igniting
as this material is highly flammable. Offer surplus and non-recyclable solutions to a licensed disposal
company.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: 1648 IMDG: 1648 IATA: 1648
UN proper shipping name
ADR/RID: ACETONITRILE, SOLUTION
IMDG: ACETONITRILE, SOLUTION
IATA: Acetonitrile, SOLUTION
Transport hazard class(es)
ADR/RID: 3 IMDG: 3 IATA: 3
Packaging group
ADR/RID: II IMDG: II IATA: II
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

---

SECTION 16: Other information
Full text of H-Statements referred to under sections 2 and 3.
Acute Tox. Acute toxicity
Eye Irrit. Eye irritation
Flam. Liq. Flammable liquids
H225 Highly flammable liquid and vapour.
H302 Harmful if swallowed.
H302 + H312 + Harmful if swallowed, in contact with skin or if inhaled
H332
H312 Harmful in contact with skin.
H319 Causes serious eye irritation.
H332 Harmful if inhaled.
Full text of R-phrases referred to under sections 2 and 3
F Highly flammable
Xn Harmful
R11 Highly flammable.
R20/21/22 Harmful by inhalation, in contact with skin and if swallowed.
R36 Irritating to eyes.
Further information
Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

制备方法与用途

生物活性

Diacetoxyscirpenol (DAS) 是一种单端孢霉烯真菌毒素，由真菌产生。摄入 DAS 可引起人类和动物血液病（如中性粒细胞减少、再生障碍性贫血）。

类别

有毒物品

毒性分级

剧毒

急性毒性

• 口服 - 大鼠 LD50: 7 毫克/公斤
• 口服 - 小鼠 LD50: 7.3 毫克/公斤

刺激数据

• 皮肤 - 豚鼠：0.284 毫克，轻度刺激

可燃性危险特性

可燃；燃烧时产生刺激烟雾

储运特性

库房需通风干燥低温存放；与食品原料分开存储

灭火剂

干粉、泡沫、沙土、二氧化碳、雾状水

文献信息

• Heterocyclically Substituted Anilinopyrimides
  申请人：Greul Jörg Nico

  公开号：US20110245242A1

  公开（公告）日：2011-10-06

  Heterocyclically substituted anilinopyrimidines of the formula (I) in which R 1 to R 10 and L 1 , L 2 , E1, E2, E3, Y and Z have the meanings given in the description, and agrochemically active salts thereof, their use and also methods and compositions for controlling phytopathogenic harmful fungi in and/or on plants or in and/or on seed of plants, processes for preparing such compositions and treated seed and also their use for controlling phytopathogenic harmful fungi in agriculture, horticulture and forestry, in the protection of materials and in the domestic and hygiene field. The present invention furthermore relates to a process for preparing heterocyclically substituted anilinopyrimidinenes of the formula (I).

  公式（I）中的杂环取代苯基嘧啶，其中R1至R10和L1、L2、E1、E2、E3、Y和Z的含义如描述中所示，以及其农药活性盐，它们的用途以及用于控制植物或植物种子中和/或上的植物病原有害真菌的方法和组合物，制备这种组合物的过程以及处理后的种子以及它们在农业、园艺和林业中用于控制植物病原有害真菌，在材料保护以及家庭和卫生领域。此外，本发明还涉及制备公式（I）中的杂环取代苯基嘧啶的方法。
• Vitamin-Receptor Binding Drug Delivery Conjugates
  申请人：Endocyte, Inc.

  公开号：US20160220694A1

  公开（公告）日：2016-08-04

  The invention describes a vitamin receptor binding drug delivery conjugate, and preparations therefor. The drug delivery conjugate consists of a vitamin receptor binding moiety, a bivalent linker (L), and a drug. The vitamin receptor binding moiety includes vitamins, and vitamin receptor binding analogs and derivatives thereof, and the drug includes analogs and derivatives thereof. The vitamin receptor binding moiety is covalently linked to the bivalent linker, and the drug, or the analog or the derivative thereof, is covalently linked to the bivalent linker, wherein the bivalent linker (L) includes components such as spacer linkers, releasable linkers, and heteroatom linkers, and combinations thereof. Methods and pharmaceutical compositions for eliminating pathogenic cell populations using the drug delivery conjugate are also described.

  该发明描述了一种维生素受体结合药物传递共轭物及其制备方法。药物传递共轭物由维生素受体结合基团、双价连接剂（L）和药物组成。维生素受体结合基团包括维生素、维生素受体结合类似物及其衍生物，药物包括类似物及其衍生物。维生素受体结合基团与双价连接剂共价连接，药物或其类似物或衍生物与双价连接剂共价连接，其中双价连接剂（L）包括间隔连接剂、可释放连接剂和杂原子连接剂以及其组合。还描述了利用该药物传递共轭物消除病原细胞群的方法和药物组合物。
• Heterocyclically Substituted Anilinopyrimidines
  申请人：Wasnaire Pierre

  公开号：US20110245249A1

  公开（公告）日：2011-10-06

  Heterocyclically substituted anilinopyrimidines of the formula (I) in which R 1 to R 12 and E1, E2, E3, L 1 , Y, Z and L 2 have the meanings given in the description, and agrochemically active salts thereof, their use and also methods and compositions for controlling phytopathogenic harmful fungi in and/or on plants or in and/or on seed of plants, processes for preparing such compositions and treated seed and also their use for controlling phytopathogenic harmful fungi in agriculture, horticulture and forestry, in the protection of materials and in the domestic and hygiene field. The present invention furthermore relates to a process for preparing heterocyclically substituted anilinopyrimidinenes of the formula (I).

  公式(I)中的杂环取代苯基嘧啶，其中R1至R12和E1、E2、E3、L1、Y、Z和L2具有描述中给出的含义，以及其农用活性盐，它们的用途以及控制植物或种子中和/或植物中和/或植物种子上的植物病原真菌的方法和组合物，用于制备这种组合物的过程以及受处理的种子，以及其在农业、园艺和林业中控制植物病原真菌的用途，在材料保护以及家庭和卫生领域。本发明还涉及制备公式(I)中的杂环取代苯基嘧啶的方法。
• Alkoxy- and Alkylthio-Substituted Anilinopyrimidines
  申请人：Greul Jörg Nico

  公开号：US20110245284A1

  公开（公告）日：2011-10-06

  Alkoxy- and alkylthio-substituted anilinopyrimidines of the formula (I) in which R 1 to R 14 and E1, E2, E3, X and Y have the meanings given in the description, and agrochemically active salts thereof, their use, and methods and compositions for controlling phytopathogenic harmful fungi in and/or on plants or in and/or on seeds of plants, processes for preparing such compositions and treated seeds and also their use for controlling phytopathogenic hal inful fungi in agriculture, horticulture and forestry, in the protection of materials and in the domestic and hygiene field. The present invention furthermore relates to a process for the preparation of alkoxy- and alkylthio-substituted anilinopyrimidines of the formula (I).

  配方（I）中的烷氧基和烷硫基取代的苯胺嘧啶化合物，其中R1至R14和E1、E2、E3、X和Y的含义如描述中所示，以及其农用活性盐、它们的用途，用于控制植物或种子中和/或上的植物病原有害真菌的方法和组合物，用于制备这种组合物的过程和处理过的种子，以及它们在农业、园艺和林业中控制植物病原有害真菌、保护材料以及在家庭和卫生领域中的用途。本发明还涉及一种制备配方（I）中的烷氧基和烷硫基取代的苯胺嘧啶化合物的方法。
• THIADIAZOLYLOXYPHENYLAMIDINES AND USE THEREOF AS FUNGICIDES
  申请人：Cristau Pierre

  公开号：US20110152080A1

  公开（公告）日：2011-06-23

  The present invention relates to thiadiazolyloxyphenylamidines of the general formula (I), to a process for the preparation thereof, to the use of the amidines according to the invention in combating undesirable microorganisms and to a composition for this purpose comprising the thiadiazolyloxyphenylamidines according to the invention. The invention furthermore relates to a method for combating undesirable microorganisms by application of the compounds according to the invention to the microorganisms and/or to the habitat thereof.

  本发明涉及一般式（I）的噻二唑氧基苯基胺类化合物，以及其制备方法，根据本发明在对抗有害微生物中使用这些胺类化合物的用途，以及包含根据本发明的噻二唑氧基苯基胺类化合物的用途的组合物。此外，本发明还涉及通过将根据本发明的化合物应用于微生物和/或其栖息地来对抗有害微生物的方法。

表征谱图